Drug Discovery Informatics Market Regional Analysis, Key Players and Forecast till 2025

Drug Discovery Informatics Market Overview:

The global drug discovery informatics market is expected to grow at a 9.3 percent compound annual growth rate (CAGR) from USD 2.2 billion in 2020 to USD 3.5 billion in 2025. Factors such as increased R&D expenditure, growing support for research, particularly in the field of rare diseases, and the increasing use of informatics in drug development are all driving market expansion. The paucity of qualified specialists and the high setup cost of informatics software, on the other hand, are projected to impede market expansion to some extent.
Download PDF:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64537381

The major companies in the drug discovery informatics market include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland). These players have adopted various growth strategies such as product launches, acquisitions, to increase their presence in the global drug discovery informatics market.

Request For Sample:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=64537381

In May 2019, Jubilant selected the CDD Vault informatics platform as its discovery research informatics platform for five years
In May, 2019, Dassault Systèmes acquired Medidata Solution adding its clinical expertise and cloud-based solutions to Dassault’s portfolio
In September 2019 Evotec collaborated with Takeda Pharmaceutical Company Limited to establish five drug discovery programs with clinical candidates from Evotec for further clinical development by Takeda across multiple therapy areas
Segmentation:

By function, the sequencing and target data analysis segment accounted for the largest share for the drug discovery informatics market.
The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.

By the end-user, the pharmaceutical companies segment accounted for the largest share of the market.
The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019; pharmaceutical companies are using this informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment.

By application, the drug development segment accounted for the largest share of the drug discovery informatics market.
The drug development segment accounted for the largest share of the drug discovery informatics market in 2019, large share of this segment is primarily attributed to the increasing investments in the research and development of new drug molecules and the growing need for time and cost optimization for drug discovery and development.

Detailed Information:

https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html

Key Players:

The major companies in the drug discovery informatics market include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland).

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com